Trending
- Fertilizer giant OCP Group and IFC sign $108M deal to tackle Morocco’s water crisis
- Why Ghana’s new-look $60M Jamestown Fishing Port is catalyst for jobs growth
- Unleash your creativity: UAE Engineering Award welcomes innovators
- China’s 6,000-troop training program in Africa: What’s the real agenda?
- How FOCAC 2024 paved the way for deeper China-Africa collaboration
- TAZARA reborn: China, Tanzania sign landmark railway revamp agreement
- Ethiopia’s forest revolution brings carbon finance billions within reach
- Senegal’s Faye declares war on people smugglers after 37 die in the Atlantic
Browsing: angiotensin-converting enzyme (ACE) inhibitor
- Dr. Patil VijaySinh, an interventional cardiologist at The Nairobi West Hospital, led the team in performing the Renal Artery Denervation procedure.
- Hypertension, commonly known as high blood pressure, is a major global health concern, contributing to an estimated 8.5 million deaths in 2015 alone.
- Innovative healthcare techniques like Renal Artery Denervation offer new hope for patients with resistant hypertension.
The Nairobi West Hospital has successfully conducted the first Renal Artery Denervation procedure for resistant hypertension in Kenya and East Africa.
This pioneering procedure marks a significant step forward in the region’s battle against hypertension, a leading cause of cardiovascular morbidity and mortality worldwide.
Hypertension, commonly known as high blood pressure, is a major global health concern, contributing to an estimated 8.5 million deaths in 2015 alone.
Despite the availability of various antihypertensive medications, only 18-23 per cent of patients achieve optimal blood pressure control.
In Kenya, prevalence of hypertension is …